{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:50:11Z","timestamp":1791726611704,"version":"4.3.4"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2019-12369583"],"award-info":[{"award-number":["GR-2019-12369583"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008594","name":"European Hematology Association","doi-asserted-by":"publisher","award":["2021"],"award-info":[{"award-number":["2021"]}],"id":[{"id":"10.13039\/100008594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.bcmd.2023.102761","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T12:11:03Z","timestamp":1685448663000},"page":"102761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Cellular and animal models for the investigation of \u03b2-thalassemia"],"prefix":"10.1016","volume":"104","author":[{"given":"Antonella","family":"Nai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Cordero-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Tanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona Maria","family":"Di Modica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2023.102761_bb0005","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/ejh.13512","article-title":"Changing patterns in the epidemiology of beta-thalassemia","volume":"105","author":"Kattamis","year":"2020","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bcmd.2023.102761_bb0010","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/bjh.13820","article-title":"Ineffective erythropoiesis and regulation of iron status in iron loading anaemias","volume":"172","author":"Camaschella","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2023.102761_bb0015","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ng.2996","article-title":"Identification of erythroferrone as an erythroid regulator of iron metabolism","volume":"46","author":"Kautz","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcmd.2023.102761_bb0020","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood-2015-07-658419","article-title":"Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of beta-thalassemia","volume":"126","author":"Kautz","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102761_bb0025","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1172\/JCI63924","article-title":"Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis","volume":"122","author":"Liu","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2023.102761_bb0030","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1136\/gutjnl-2013-305317","article-title":"Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB","volume":"63","author":"Sonnweber","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.bcmd.2023.102761_bb0035","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/asheducation-2017.1.265","article-title":"Iron overload in thalassemia: different organs at different rates","volume":"2017","author":"Taher","year":"2017","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.bcmd.2023.102761_bb0040","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMra2021838","article-title":"beta-Thalassemias","volume":"384","author":"Taher","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2023.102761_bb0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/bjh.14776","article-title":"Serum ferritin in the diagnosis of cardiac and liver iron overload in thalassaemia patients real-world practice: a multicentre study","volume":"182","author":"Krittayaphong","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2023.102761_bb0050","doi-asserted-by":"crossref","first-page":"E35","DOI":"10.1002\/ajh.24628","article-title":"Serum ferritin values between 300 and 800\u00a0ng\/mL in nontransfusion-dependent thalassemia: a probability curve to guide clinical decision making when MRI is unavailable","volume":"92","author":"Saliba","year":"2017","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2023.102761_bb0055","unstructured":"A.T. Taher, P.I. Tyan, M.D. Cappellini, The spleen, in: M.D. Cappellini, A. Cohen, J. Porter, A.T. Taher, V. Viprakasit (Eds.) Guidelines for the Management of Transfusion Dependent Thalassaemia, (TIF2014)."},{"key":"10.1016\/j.bcmd.2023.102761_bb0060","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.3324\/haematol.2019.245688","article-title":"History of hematopoietic cell transplantation: challenges and progress","volume":"105","author":"Granot","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2023.102761_bb0065","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1056\/NEJMoa1705342","article-title":"Gene therapy in patients with transfusion-dependent beta-thalassemia","volume":"378","author":"Thompson","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2023.102761_bb0070","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41591-018-0301-6","article-title":"Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ss-thalassemia","volume":"25","author":"Marktel","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcmd.2023.102761_bb0075","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa2113206","article-title":"Betibeglogene autotemcel gene therapy for non-beta(0)\/beta(0) genotype beta-thalassemia","volume":"386","author":"Locatelli","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2023.102761_bb0080","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/cpt.1639","article-title":"Regulators\u2019 advice can make a difference: European medicines agency approval of zynteglo for beta thalassemia","volume":"107","author":"Schuessler-Lenz","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bcmd.2023.102761_bb0085","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41434-020-0153-9","article-title":"Advances in genome editing: the technology of choice for precise and efficient beta-thalassemia treatment","volume":"28","author":"Ali","year":"2021","journal-title":"Gene Ther."},{"key":"10.1016\/j.bcmd.2023.102761_bb0090","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1182\/blood-2011-09-382408","article-title":"Fetal hemoglobin levels and morbidity in untransfused patients with beta-thalassemia intermedia","volume":"119","author":"Musallam","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102761_bb0095","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ejphar.2019.04.042","article-title":"Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: a promising approach for gene therapy of beta thalassemia disease","volume":"854","author":"Khosravi","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcmd.2023.102761_bb0100","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and beta-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2023.102761_bb0105","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1038\/s41591-022-01906-z","article-title":"CRISPR-Cas9-mediated gene editing of the BCL11A enhancer for pediatric beta(0)\/beta(0) transfusion-dependent beta-thalassemia","volume":"28","author":"Fu","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcmd.2023.102761_bb0110","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3324\/haematol.2019.232124","article-title":"Iron metabolism and iron disorders revisited in the hepcidin era","volume":"105","author":"Camaschella","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2023.102761_bb0115","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.hoc.2022.12.010","article-title":"Emerging therapies in beta-thalassemia","volume":"37","author":"Bou-Fakhredin","year":"2023","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.bcmd.2023.102761_bb0120","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1182\/blood-2012-01-401885","article-title":"Deletion of TMPRSS6 attenuates the phenotype in a mouse model of beta-thalassemia","volume":"119","author":"Nai","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102761_bb0125","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1172\/JCI66969","article-title":"Reducing TMPRSS6 ameliorates hemochromatosis and beta-thalassemia in mice","volume":"123","author":"Guo","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2023.102761_bb0130","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.3324\/haematol.2015.133348","article-title":"Combination of Tmprss6-ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia","volume":"101","author":"Casu","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2023.102761_bb0135","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood-2012-09-453977","article-title":"An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(\u2212\/\u2212) mice and ameliorates anemia and iron overload in murine beta-thalassemia intermedia","volume":"121","author":"Schmidt","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102761_bb0140","series-title":"Transmembrane Protease, Serine 6 (TMPRSS6) Antisense Oligonucleotide (IONIS-TMPRSS6-LRX) Reduces Plasma Iron Levels of Healthy Volunteers in a Phase 1 Clinical Study","first-page":"3634","author":"McCaleb","year":"2018"},{"key":"10.1016\/j.bcmd.2023.102761_bb0145","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nm.3512","article-title":"Transforming growth factor-beta superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis","volume":"20","author":"Suragani","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcmd.2023.102761_bb0150","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1182\/blood-2013-06-511238","article-title":"Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine beta-thalassemia","volume":"123","author":"Suragani","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102761_bb0155","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nm.3468","article-title":"An activin receptor IIA ligand trap corrects ineffective erythropoiesis in beta-thalassemia","volume":"20","author":"Dussiot","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcmd.2023.102761_bb0160","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1056\/NEJMoa1910182","article-title":"A phase 3 trial of luspatercept in patients with transfusion-dependent beta-thalassemia","volume":"382","author":"Cappellini","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2023.102761_bb0165","doi-asserted-by":"crossref","first-page":"e733","DOI":"10.1016\/S2352-3026(22)00208-3","article-title":"Luspatercept for the treatment of anaemia in non-transfusion-dependent beta-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial","volume":"9","author":"Taher","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.bcmd.2023.102761_bb0170","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s40265-019-01251-5","article-title":"Luspatercept: first approval","volume":"80","author":"Markham","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.bcmd.2023.102761_bb0175","first-page":"505","article-title":"Erythrocytic maturation in vitro of murine (Friend) virus-induced leukemic cells","volume":"22","author":"Friend","year":"1966","journal-title":"Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.bcmd.2023.102761_bb0180","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ijc.2910190119","article-title":"Properties of the K562 cell line derived from a patient with chronic myeloid leukemia","volume":"19","author":"Lozzio","year":"1977","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcmd.2023.102761_bb0185","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/280164a0","article-title":"K562 human leukaemic cells synthesise embryonic haemoglobin in response to haemin","volume":"280","author":"Rutherford","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2023.102761_bb0190","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1073\/pnas.68.2.378","article-title":"Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide","volume":"68","author":"Friend","year":"1971","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2023.102761_bb0195","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1182\/blood.V71.1.104.104","article-title":"Expression and modulation of specific, high affinity binding sites for erythropoietin on the human erythroleukemic cell line K562","volume":"71","author":"Fraser","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102761_bb0200","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.exphem.2018.02.007","article-title":"High-level embryonic globin production with efficient erythroid differentiation from a K562 erythroleukemia cell line","volume":"62","author":"Uchida","year":"2018","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bcmd.2023.102761_bb0205","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.exphem.2020.01.012","article-title":"K562 erythroleukemia line as a possible reticulocyte source to culture Plasmodium vivax and its surrogates","volume":"82","author":"Kronstein-Wiedemann","year":"2020","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bcmd.2023.102761_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001544","article-title":"Establishment of mouse embryonic stem cell-derived erythroid progenitor cell lines able to produce functional red blood cells","volume":"3","author":"Hiroyama","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2023.102761_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059890","article-title":"Establishment of immortalized human erythroid progenitor cell lines able to produce enucleated red blood cells","volume":"8","author":"Kurita","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2023.102761_bb0220","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/bloodadvances.2020001996","article-title":"Correction of beta-thalassemia by CRISPR\/Cas9 editing of the alpha-globin locus in human hematopoietic stem cells","volume":"5","author":"Pavani","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.bcmd.2023.102761_bb0225","article-title":"Prime editor 3 mediated beta-thalassemia mutations of the HBB gene in human erythroid progenitor cells","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcmd.2023.102761_bb0230","article-title":"Human cellular model systems of \u03b2-thalassemia enable in-depth analysis of disease phenotype","author":"Daniels","year":"2022","journal-title":"Biorxiv"},{"key":"10.1016\/j.bcmd.2023.102761_bb0235","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.3324\/haematol.2019.229211","article-title":"Comparing the two leading erythroid lines BEL-A and HUDEP-2","volume":"105","author":"Daniels","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2023.102761_bb0240","doi-asserted-by":"crossref","first-page":"16798","DOI":"10.1038\/s41598-020-73991-4","article-title":"Generation of an immortalised erythroid cell line from haematopoietic stem cells of a haemoglobin E\/beta-thalassemia patient","volume":"10","author":"Trakarnsanga","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcmd.2023.102761_bb0245","first-page":"32","article-title":"Erythroid progenitors in mouse bone marrow detected by macroscopic colony formation in culture","volume":"3","author":"Iscove","year":"1975","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bcmd.2023.102761_bb0250","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood.V73.1.100.100","article-title":"Proliferation and maturation of human erythroid progenitors in liquid culture","volume":"73","author":"Fibach","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102761_bb0255","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jcyt.2013.04.002","article-title":"A stromal-free, serum-free system to expand ex vivo hematopoietic stem cells from mobilized peripheral blood of patients with hematologic malignancies and healthy donors","volume":"15","author":"Yao","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bcmd.2023.102761_bb0260","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/trf.12391","article-title":"Mononuclear cells from a rare blood donor, after freezing under good manufacturing practice conditions, generate red blood cells that recapitulate the rare blood phenotype","volume":"54","author":"Masiello","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.bcmd.2023.102761_bb0265","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.exphem.2005.06.014","article-title":"A hanging drop culture method to study terminal erythroid differentiation","volume":"33","author":"Gutierrez","year":"2005","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bcmd.2023.102761_bb0270","doi-asserted-by":"crossref","first-page":"8737","DOI":"10.1073\/pnas.0701829104","article-title":"In vitro erythropoiesis from bone marrow-derived progenitors provides a physiological assay for toxic and mutagenic compounds","volume":"104","author":"Shuga","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2023.102761_bb0275","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1096\/fj.00-0705fje","article-title":"Establishment of normal, terminally differentiating mouse erythroid progenitors: molecular characterization by cDNA arrays","volume":"15","author":"Dolznig","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.bcmd.2023.102761_bb0280","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-1-4939-7428-3_4","article-title":"Dissecting regulatory mechanisms using mouse fetal liver-derived erythroid cells","volume":"1698","author":"McIver","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bcmd.2023.102761_bb0285","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/jcb.29377","article-title":"Generation of an in vitro model of beta-thalassemia using the CRISPR\/Cas9 genome editing system","volume":"121","author":"Ajami","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bcmd.2023.102761_bb0290","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.bbmt.2017.05.003","article-title":"Sources of hematopoietic stem and progenitor cells and methods to optimize yields for clinical cell therapy","volume":"23","author":"Panch","year":"2017","journal-title":"Biol. Blood Marrow Transplant"},{"key":"10.1016\/j.bcmd.2023.102761_bb0295","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s40291-018-0373-5","article-title":"Oxidative stress in beta-thalassemia","volume":"23","author":"Fibach","year":"2019","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.bcmd.2023.102761_bb0300","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000258958","article-title":"Effect of iron chelators on labile iron and oxidative status of thalassaemic erythroid cells","volume":"123","author":"Prus","year":"2010","journal-title":"Acta Haematol."},{"key":"10.1016\/j.bcmd.2023.102761_bb0305","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0037-1963(01)90032-0","article-title":"Cell culture and animal models to screen for promising fetal hemoglobin-stimulating compounds","volume":"38","author":"Fibach","year":"2001","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.bcmd.2023.102761_bb0310","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-6632.2010.05594.x","article-title":"A preclinical approach for gene therapy of beta-thalassemia","volume":"1202","author":"Breda","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bcmd.2023.102761_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032345","article-title":"Therapeutic hemoglobin levels after gene transfer in beta-thalassemia mice and in hematopoietic cells of beta-thalassemia and sickle cells disease patients","volume":"7","author":"Breda","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2023.102761_bb0320","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.omtm.2021.03.025","article-title":"Efficient CRISPR-Cas9-based genome editing of beta-globin gene on erythroid cells from homozygous beta(0)39-thalassemia patients","volume":"21","author":"Cosenza","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.bcmd.2023.102761_bb0325","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13287-022-02768-5","article-title":"Genetic correction of concurrent alpha- and beta-thalassemia patient-derived pluripotent stem cells by the CRISPR-Cas9 technology","volume":"13","author":"Li","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.bcmd.2023.102761_bb0330","article-title":"A synthetic model of human beta-thalassemia erythropoiesis using CD34+ cells from healthy adult donors","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2023.102761_bb0335","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/sctm.20-0247","article-title":"Hematopoietic stem cells from pluripotent stem cells: clinical potential, challenges, and future perspectives","volume":"9","author":"Demirci","year":"2020","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.bcmd.2023.102761_bb0340","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1089\/scd.2011.0078","article-title":"Generation of red blood cells from human induced pluripotent stem cells","volume":"20","author":"Dias","year":"2011","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.bcmd.2023.102761_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100874","article-title":"Qualitative and quantitative comparison of the proteome of erythroid cells differentiated from human iPSCs and adult erythroid cells by multiplex TMT labelling and nanoLC-MS\/MS","volume":"9","author":"Trakarnsanga","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2023.102761_bb0350","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12967-016-1016-4","article-title":"A validated cellular biobank for beta-thalassemia","volume":"14","author":"Cosenza","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bcmd.2023.102761_bb0355","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bjh.17167","article-title":"Induction of therapeutic levels of HbF in genome-edited primary beta(0) 39-thalassaemia haematopoietic stem and progenitor cells","volume":"192","author":"Mingoia","year":"2021","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2023.102761_bb0360","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3324\/haematol.2020.248013","article-title":"Sex-specific transcriptional profiles identified in beta-thalassemia patients","volume":"106","author":"Nanou","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2023.102761_bb0365","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1182\/blood.V47.3.495.495","article-title":"Lipid membrane peroxidation in beta-thalassemia major","volume":"47","author":"Rachmilewitz","year":"1976","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102761_bb0370","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1182\/blood.V70.1.158.158","article-title":"Erythrocyte membrane skeleton abnormalities in severe beta-thalassemia","volume":"70","author":"Shinar","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102761_bb0375","doi-asserted-by":"crossref","first-page":"19092","DOI":"10.1016\/S0021-9258(19)47271-2","article-title":"A study of membrane protein defects and alpha hemoglobin chains of red blood cells in human beta thalassemia","volume":"264","author":"Rouyer-Fessard","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2023.102761_bb0380","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1182\/blood.V74.6.2194.2194","article-title":"Cellular and membrane properties of alpha and beta thalassemic erythrocytes are different: implication for differences in clinical manifestations","volume":"74","author":"Schrier","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102761_bb0385","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0009-8981(00)00428-9","article-title":"Antioxidant defense status of red blood cells of patients with beta-thalassemia and Ebeta-thalassemia","volume":"305","author":"Chakraborty","year":"2001","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bcmd.2023.102761_bb0390","doi-asserted-by":"crossref","first-page":"17953","DOI":"10.1016\/S0021-9258(18)38256-5","article-title":"Entrapment of purified alpha-hemoglobin chains in normal erythrocytes. A model for beta thalassemia","volume":"265","author":"Scott","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2023.102761_bb0395","series-title":"Beta Thalassemia","article-title":"Model Human \u03b2 thalassemic erythrocytes: effect of unpaired purified \u03b1-hemoglobin chains on normal erythrocytes","author":"Scott","year":"2020"},{"key":"10.1016\/j.bcmd.2023.102761_bb0400","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/0092-8674(83)90562-7","article-title":"A mouse model for beta-thalassemia","volume":"34","author":"Skow","year":"1983","journal-title":"Cell"},{"key":"10.1016\/j.bcmd.2023.102761_bb0405","doi-asserted-by":"crossref","first-page":"16126","DOI":"10.1016\/S0021-9258(18)66687-6","article-title":"Compensatory increase in levels of beta minor globin in murine beta-thalassemia is under translational control","volume":"261","author":"Curcio","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2023.102761_bb0410","doi-asserted-by":"crossref","first-page":"14380","DOI":"10.1073\/pnas.212507099","article-title":"Permanent and panerythroid correction of murine beta thalassemia by multiple lentiviral integration in hematopoietic stem cells","volume":"99","author":"Imren","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2023.102761_bb0415","first-page":"1336","article-title":"Liver expression of hepcidin and other iron genes in two mouse models of beta-thalassemia","volume":"91","author":"De Franceschi","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2023.102761_bb0420","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1161\/CIRCULATIONAHA.112.130179","article-title":"Hemopexin therapy improves cardiovascular function by preventing heme-induced endothelial toxicity in mouse models of hemolytic diseases","volume":"127","author":"Vinchi","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.bcmd.2023.102761_bb0425","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1182\/blood-2012-09-456079","article-title":"Quantitative analysis of murine terminal erythroid differentiation in vivo: novel method to study normal and disordered erythropoiesis","volume":"121","author":"Liu","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102761_bb0430","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1101\/gad.267633.115","article-title":"Erythropoietin and IGF-1 signaling synchronize cell proliferation and maturation during erythropoiesis","volume":"29","author":"Kadri","year":"2015","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcmd.2023.102761_bb0435","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1073\/pnas.90.8.3177","article-title":"Lethal thalassemia after insertional disruption of the mouse major adult beta-globin gene","volume":"90","author":"Shehee","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2023.102761_bb0440","doi-asserted-by":"crossref","first-page":"9259","DOI":"10.1073\/pnas.92.20.9259","article-title":"Mouse model of human beta zero thalassemia: targeted deletion of the mouse beta maj- and beta min-globin genes in embryonic stem cells","volume":"92","author":"Ciavatta","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2023.102761_bb0445","doi-asserted-by":"crossref","first-page":"11608","DOI":"10.1073\/pnas.92.25.11608","article-title":"A mouse model for beta 0-thalassemia","volume":"92","author":"Yang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2023.102761_bb0450","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00223-010-9365-0","article-title":"Changes in bone microarchitecture and biomechanical properties in the th3 thalassemia mouse are associated with decreased bone turnover and occur during the period of bone accrual","volume":"86","author":"Vogiatzi","year":"2010","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bcmd.2023.102761_bb0455","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2015-10-676742","article-title":"Minihepcidin peptides as disease modifiers in mice affected by beta-thalassemia and polycythemia vera","volume":"128","author":"Casu","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102761_bb0460","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1172\/JCI129382","article-title":"Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of beta-thalassemia","volume":"130","author":"Manolova","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2023.102761_bb0465","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3324\/haematol.2014.117325","article-title":"Reversal of hemochromatosis by apotransferrin in non-transfused and transfused Hbbth3\/+ (heterozygous B1\/B2 globin gene deletion) mice","volume":"100","author":"Gelderman","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2023.102761_bb0470","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1182\/blood-2016-09-742387","article-title":"Decreasing TfR1 expression reverses anemia and hepcidin suppression in beta-thalassemic mice","volume":"129","author":"Li","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102761_bb0475","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1182\/blood-2018-05-852277","article-title":"Transferrin receptor 2 is a potential novel therapeutic target for beta-thalassemia: evidence from a murine model","volume":"132","author":"Artuso","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102761_bb0480","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ajh.23934","article-title":"Combination therapy with a Tmprss6 RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of beta-thalassemia intermedia","volume":"90","author":"Schmidt","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2023.102761_bb0485","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/bjh.17428","article-title":"SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron-overload in a mouse model of beta-thalassaemia","volume":"194","author":"Vadolas","year":"2021","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2023.102761_bb0490","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1525-0016(03)00043-1","article-title":"Regulated expression of erythropoietin from an AAV vector safely improves the anemia of beta-thalassemia in a mouse model","volume":"7","author":"Johnston","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bcmd.2023.102761_bb0495","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1182\/blood.2019004719","article-title":"Correcting beta-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity","volume":"136","author":"Casu","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102761_bb0500","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1182\/blood.2019001057","article-title":"Lack of Gdf11 does not improve anemia or prevent the activity of RAP-536 in a mouse model of beta-thalassemia","volume":"134","author":"Guerra","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102761_bb0505","doi-asserted-by":"crossref","first-page":"6162","DOI":"10.1111\/jcmm.15243","article-title":"Smad2\/3-pathway ligand trap luspatercept enhances erythroid differentiation in murine beta-thalassaemia by increasing GATA-1 availability","volume":"24","author":"Martinez","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bcmd.2023.102761_bb0510","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2141.1993.tb03106.x","article-title":"Improvement of mouse beta thalassaemia by hydroxyurea","volume":"84","author":"Sauvage","year":"1993","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2023.102761_bb0515","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/35017565","article-title":"Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin","volume":"406","author":"May","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2023.102761_bb0520","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1182\/blood-2002-07-2211","article-title":"The degree of phenotypic correction of murine beta-thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy number","volume":"101","author":"Persons","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102761_bb0525","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1182\/blood-2007-08-108647","article-title":"Locus control region elements HS1 and HS4 enhance the therapeutic efficacy of globin gene transfer in beta-thalassemic mice","volume":"110","author":"Lisowski","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102761_bb0530","doi-asserted-by":"crossref","first-page":"10547","DOI":"10.1073\/pnas.0711666105","article-title":"In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of beta-thalassemia","volume":"105","author":"Miccio","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2023.102761_bb0535","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1182\/blood-2002-10-3305","article-title":"A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer","volume":"101","author":"Rivella","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102761_bb0540","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1182\/blood-2007-12-126938","article-title":"Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemia","volume":"112","author":"Libani","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102761_bb0545","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3324\/haematol.2018.212589","article-title":"Minihepcidins improve ineffective erythropoiesis and splenomegaly in a new mouse model of adult beta-thalassemia major","volume":"105","author":"Casu","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2023.102761_bb0550","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/ajh.26673","article-title":"Transferrin receptor 2 (Tfr2) genetic deletion makes transfusion-independent a murine model of transfusion-dependent beta-thalassemia","volume":"97","author":"Di Modica","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2023.102761_bb0555","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1182\/blood.V91.6.2152","article-title":"A common human beta globin splicing mutation modeled in mice","volume":"91","author":"Lewis","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102761_bb0560","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1073\/pnas.0812436106","article-title":"RNA repair restores hemoglobin expression in IVS2-654 thalassemic mice","volume":"106","author":"Svasti","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2023.102761_bb0565","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12185-010-0727-1","article-title":"Correction of beta654-thalassaemia mice using direct intravenous injection of siRNA and antisense RNA vectors","volume":"93","author":"Xie","year":"2011","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.bcmd.2023.102761_bb0570","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ygeno.2006.03.009","article-title":"A humanized BAC transgenic\/knockout mouse model for HbE\/beta-thalassemia","volume":"88","author":"Jamsai","year":"2006","journal-title":"Genomics"},{"key":"10.1016\/j.bcmd.2023.102761_bb0575","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ygeno.2004.11.016","article-title":"A humanized mouse model for a common beta0-thalassemia mutation","volume":"85","author":"Jamsai","year":"2005","journal-title":"Genomics"},{"key":"10.1016\/j.bcmd.2023.102761_bb0580","doi-asserted-by":"crossref","first-page":"7399","DOI":"10.1074\/jbc.M512931200","article-title":"Humanized beta-thalassemia mouse model containing the common IVSI-110 splicing mutation","volume":"281","author":"Vadolas","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2023.102761_bb0585","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1074\/jbc.M805681200","article-title":"Humanized mouse model of Cooley\u2019s anemia","volume":"284","author":"Huo","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2023.102761_bb0590","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/687635","article-title":"Generation and characterization of a transgenic mouse carrying a functional human beta-globin gene with the IVSI-6 thalassemia mutation","volume":"2015","author":"Breveglieri","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bcmd.2023.102761_bb0595","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1182\/blood-2004-04-1427","article-title":"Successful correction of the human beta-thalassemia major phenotype using a lentiviral vector","volume":"104","author":"Puthenveetil","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102761_bb0600","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.stemcr.2016.08.005","article-title":"Improved human erythropoiesis and platelet formation in humanized NSGW41 mice","volume":"7","author":"Rahmig","year":"2016","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.bcmd.2023.102761_bb0605","doi-asserted-by":"crossref","first-page":"E513","DOI":"10.1002\/ajh.24805","article-title":"Developmentally-faithful and effective human erythropoiesis in immunodeficient and Kit mutant mice","volume":"92","author":"Fiorini","year":"2017","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2023.102761_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100464","article-title":"CRISPR\/Cas9-mediated beta-globin gene knockout in rabbits recapitulates human beta-thalassemia","volume":"296","author":"Yang","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2023.102761_bb0615","series-title":"Rabbit Biotechnology","first-page":"49","article-title":"Rabbit as a model for the study of human diseases","author":"Shiomi","year":"2009"},{"key":"10.1016\/j.bcmd.2023.102761_bb0620","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s13238-019-0627-y","article-title":"HBB-deficient Macaca fascicularis monkey presents with human beta-thalassemia","volume":"10","author":"Huang","year":"2019","journal-title":"Protein Cell"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979623000384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979623000384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:02:39Z","timestamp":1777608159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979623000384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":124,"alternative-id":["S1079979623000384"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2023.102761","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cellular and animal models for the investigation of \u03b2-thalassemia","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2023.102761","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102761"}}